Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Illinois Tool Works Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $74.9B | |
|---|---|---|
| P/E (forward) | 21.9x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $14.46B | $15.93B | $16.11B | $15.90B | $16.04B | +2.6% |
| Gross profit | $5.97B | $6.50B | $6.79B | $6.94B | $7.08B | +4.4% |
| Operating income | $3.48B | $3.79B | $4.04B | $4.26B | $4.22B | +4.9% |
| Net income | $2.69B | $3.03B | $2.96B | $3.49B | $3.07B | +3.3% |
| EPS (diluted) | $8.51 | $9.77 | $9.74 | $11.71 | $10.49 | +5.4% |
| EBITDA | $3.66B | $4.18B | $4.04B | $5.11B | $4.65B | +6.2% |
| R&D | $239.0M | $269.0M | $284.0M | $292.0M | $302.0M | +6.0% |
| SG&A | $2.36B | $2.58B | $2.62B | $2.68B | $2.78B | +4.2% |
Recent company headlines from major financial publishers.
Under the base path, ITW delivers disciplined operational execution across operating segments. Free cash flow conversion exceeds guided benchmarks, supporting dividend compounding and regular share repurchases. Discounted at the house cost of equity with normalized terminal valuation multiples, this yields the central Fair value of $195.02.
Global industrial demand accelerates across North America, EMEA, and Asia Pacific. Accelerated adoption of Customer-Back Innovation products expands market share while operational cell efficiencies deliver strong incremental margins. Free cash flow conversion exceeds net earnings, funding accelerated buybacks that expand diluted share compounding and lift intrinsic valuation toward Potential value of $222.75.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.3% | $207 | $211 | $215 | $219 | $224 |
| 8.8% | $198 | $201 | $204 | $208 | $212 |
| 9.3% | $190 | $192 | $195 | $198 | $201 |
| 9.8% | $183 | $185 | $187 | $190 | $192 |
| 10.3% | $176 | $178 | $180 | $182 | $184 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
